Case Control Study
Copyright ©The Author(s) 2018.
World J Clin Cases. Aug 16, 2018; 6(8): 192-199
Published online Aug 16, 2018. doi: 10.12998/wjcc.v6.i8.192
Table 1 Baseline clinicopathological characteristics
VariablesSeroclearance (n = 72)Non-seroclearance (n = 216)P value
Ages [median (range)]63.5 ± 8.957.0 ± 9.0< 0.001
Sex (male:female)59:17171:450.871
Hemoglobin (mg/dL)130.6 ± 28.0135.3 ± 21.70.144
Platelet count (× 109/µL)163.2 ± 87.5126.7 ± 76.20.001
PTA (%)90.5 ± 20.787.7 ± 18.50.282
Albumin (g/L)40.5 ± 5.640.1 ± 5.90.675
AST (IU/L)33.3 ± 28.639.9 ± 36.70.163
ALT (IU/L)36.9 ± 40.742.4 ± 41.70.327
TBil (µmol/L)21.2 ± 20.919.8 ± 17.50.567
AFP (ng/mL)
≤ 15361000.456
15-2001954
≥ 2001762
Size of tumor (cm) [median (range)]5.4 (1-15.4)4.35 (1-15)0.064
Number of tumor nodules
Solitary511380.318
Multiple2178
Treatment
Resection2678-
Ablation Tx2369
TACE2678
AJCC 8th edition
Stage I41123-
Stage II927
Stage III2266
Child-Pugh grade
A67171-
B1442
C13
Table 2 Baseline clinicopathological characteristics for the resection group
VariablesSeroclearance (n = 26)Non-seroclearance (n = 78)P value
Ages (median)61.6 ± 10.156.4 ± 8.40.010
Sex (male:female)22:669:90.216
Hemoglobin (mg/dL)138.3 ± 21.0142.1 ± 18.70.385
Platelet count (× 109/µL)197.7 ± 91.6154.8 ± 81.70.026
PTA (%)96.9 ± 16.294.5 ± 17.80.538
Albumin (g/L)41.8 ± 4.342.2 ± 4.80.716
AST (IU/L)37.7 ± 39.542.7 ± 33.90.529
ALT (IU/L)41.4 ± 41.641.2 ± 46.70.985
TBil (µmol/L)19.7 ± 23.217.4 ± 14.80.570
AFP (ng/mL)
≤ 1512300.581
15-200523
≥ 200925
Size of tumor (cm) [median (range)]7.2 (2.3-15.4)6.1 (2.3-15)0.140
Number of tumor nodules
Solitary20490.235
Multiple629
Pathological type
HCC18740.002
ICC32
CHC52
Cell differentiated degree
Highly differentiated5130.180
Moderately differentiated1148
Poorly differentiated1017
Liver cirrhosis
Yes20680.221
No610
AJCC 8th edition
Stage I1442-
Stage II26
Stage III1030
Child-Pugh grade
A2575-
B13
C00